NM_017534.6:c.4774C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017534.6(MYH2):​c.4774C>A​(p.Leu1592Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00169 in 1,614,042 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 35 hom. )

Consequence

MYH2
NM_017534.6 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:7

Conservation

PhyloP100: -0.436

Publications

4 publications found
Variant links:
Genes affected
MYH2 (HGNC:7572): (myosin heavy chain 2) Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in inclusion body myopathy-3. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Sep 2009]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009239972).
BP6
Variant 17-10524954-G-T is Benign according to our data. Variant chr17-10524954-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260825.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00107 (163/152192) while in subpopulation SAS AF = 0.012 (58/4814). AF 95% confidence interval is 0.00957. There are 0 homozygotes in GnomAd4. There are 86 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 35 SD,AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017534.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH2
NM_017534.6
MANE Select
c.4774C>Ap.Leu1592Met
missense
Exon 34 of 40NP_060004.3
MYH2
NM_001100112.2
c.4774C>Ap.Leu1592Met
missense
Exon 34 of 40NP_001093582.1
MYHAS
NR_125367.1
n.168-42583G>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH2
ENST00000245503.10
TSL:1 MANE Select
c.4774C>Ap.Leu1592Met
missense
Exon 34 of 40ENSP00000245503.5
MYH2
ENST00000532183.6
TSL:1
c.1975-3522C>A
intron
N/AENSP00000433944.1
MYH2
ENST00000622564.4
TSL:1
c.1975-3522C>A
intron
N/AENSP00000482463.1

Frequencies

GnomAD3 genomes
AF:
0.00107
AC:
163
AN:
152074
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000917
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.0120
Gnomad FIN
AF:
0.000284
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000956
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00270
AC:
678
AN:
251450
AF XY:
0.00353
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000578
Gnomad ASJ exome
AF:
0.000595
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.00101
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00176
AC:
2571
AN:
1461850
Hom.:
35
Cov.:
33
AF XY:
0.00219
AC XY:
1595
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.000358
AC:
12
AN:
33480
American (AMR)
AF:
0.000738
AC:
33
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000574
AC:
15
AN:
26136
East Asian (EAS)
AF:
0.000605
AC:
24
AN:
39700
South Asian (SAS)
AF:
0.0164
AC:
1414
AN:
86252
European-Finnish (FIN)
AF:
0.000712
AC:
38
AN:
53394
Middle Eastern (MID)
AF:
0.00451
AC:
26
AN:
5768
European-Non Finnish (NFE)
AF:
0.000798
AC:
887
AN:
1112000
Other (OTH)
AF:
0.00202
AC:
122
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.412
Heterozygous variant carriers
0
109
218
326
435
544
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00107
AC:
163
AN:
152192
Hom.:
0
Cov.:
32
AF XY:
0.00116
AC XY:
86
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41528
American (AMR)
AF:
0.000916
AC:
14
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5172
South Asian (SAS)
AF:
0.0120
AC:
58
AN:
4814
European-Finnish (FIN)
AF:
0.000284
AC:
3
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000956
AC:
65
AN:
68016
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000825
Hom.:
0
Bravo
AF:
0.000854
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00314
AC:
381

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
2
Myopathy, proximal, and ophthalmoplegia (3)
-
-
3
not specified (3)
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
16
DANN
Benign
0.95
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.53
T
MetaRNN
Benign
0.0092
T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
1.9
L
PhyloP100
-0.44
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.73
N
REVEL
Benign
0.15
Sift
Benign
0.091
T
Sift4G
Benign
0.22
T
Polyphen
0.015
B
Vest4
0.22
MVP
0.52
MPC
0.35
ClinPred
0.0027
T
GERP RS
1.3
Varity_R
0.096
gMVP
0.13
Mutation Taster
=98/2
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138393827; hg19: chr17-10428271; COSMIC: COSV106082549; API